Birgit C. Schultes

Insider Reports History

Location
Cambridge, MA
Signature
James Basta, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Birgit C. Schultes:

Company Role Class Num Shares Value Price $ Report Date Ownership
Intellia Therapeutics, Inc. EVP, Chief Scientific Officer Common Stock 137,733 $1,720,285 $12.49 01 Mar 2026 Direct
Intellia Therapeutics, Inc. EVP, Chief Scientific Officer Stock Option (right to buy) 56,000 01 Mar 2026 Direct

Insider Reports Filed by Birgit C. Schultes

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NTLA Intellia Therapeutics, Inc. 01 Mar 2026 2 $0 4 EVP, Chief Scientific Officer 03 Mar 2026, 16:17
NTLA Intellia Therapeutics, Inc. 05 Jan 2026 1 -$78,359 4 EVP, Chief Scientific Officer 07 Jan 2026, 16:05
NTLA Intellia Therapeutics, Inc. 01 Oct 2025 1 -$539 4 EVP, Chief Scientific Officer 03 Oct 2025, 17:13
NTLA Intellia Therapeutics, Inc. 01 Mar 2025 2 $0 4 EVP, Chief Scientific Officer 04 Mar 2025, 16:24
NTLA Intellia Therapeutics, Inc. 13 Jan 2025 0 $0 3 EVP, Chief Scientific Officer 23 Jan 2025, 17:41